The global nerve repair and regeneration market size is calculated at USD 10.25 billion in 2024, grew to USD 11.5 billion in 2025, and is projected to reach around USD 32.4 billion by 2034. The market is expanding at a CAGR of 12.2% between 2024 and 2034.
Top Companies in the Nerve Repair and Regeneration Market
Paul Anderson, Managing Director, Orthocell Ltd., reported the June quarter revenue of $1.84 million, an increase of 14.4% from the previous quarter and a 10% increase from last year. He said that the surge in revenue was due to Orthocell’s market-leading products Striate+, a non-invasive treatment for dental bone regeneration, and Remplir, a game-changing solution for people with damaged nerves or peripheral nerve pain.
If you have any questions, please feel free to contact us at sales@towardshealthcare.com